Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
276studies shown
Showing 61-72 of 276
Drug study icon
CompletedNCT03097133

Intranasal Esketamine for depression

This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.

In Belgium
Depression, SuicidalityDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
CompletedEUCTR 2013-001694-24

Effectiveness of LURASIDONE in schizophrenia

This study is completed in France, in the United Kingdom, in Belgium, .... It is testing LURASIDONE for schizophrenia.

In Belgium
SchizophreniaOther
Countries
France, United Kingdom, Belgium, ...
Sponsor
SUNOVION PHARMACEUTICALS INC.
Condition
Schizophrenia
Drug study icon
CompletedNCT01714713

EVP-6124 (Alpha-7 nAChR) for schizophrenia

This study is completed in the United States, in Australia, in Canada, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.

In Belgium
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, Australia, Canada, ...
Sponsor
FORUM Pharmaceuticals Inc
Condition
Schizophrenia
Other study type icon
CompletedEUCTR 2010-021533-31

Ritalin® LA for ADHD

This study is completed in Belgium, in Germany, in Sweden, .... It is testing Ritalin® LA for ADHD.

In Belgium
ADHDOther
Countries
Belgium, Germany, Sweden, ...
Sponsor
Novartis Pharma Services AG
Condition
ADHD
Drug study icon
CompletedEUCTR 2008-002699-83

Effectiveness of aripiprazole Intramuscular Depot in schizophrenia

This study is completed in France, in the United Kingdom, in Belgium, .... It is testing aripiprazole Intramuscular Depot for schizophrenia.

In Belgium
SchizophreniaOther
Countries
France, United Kingdom, Belgium, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Other study type icon
CompletedEUCTR 2011-000210-19

Ritalin® LA for ADHD

This study is completed in Belgium, in Germany, in Sweden, .... It is testing Ritalin® LA for ADHD.

In Belgium
ADHDOther
Countries
Belgium, Germany, Sweden, ...
Sponsor
Novartis Pharma Services AG
Condition
ADHD
Drug study icon
CompletedEUCTR 2013-001695-38

LURASIDONE for schizophrenia

This study is completed in France, in the United Kingdom, in Belgium, .... It is testing LURASIDONE for schizophrenia.

In Belgium
SchizophreniaOther
Countries
France, United Kingdom, Belgium, ...
Sponsor
SUNOVION PHARMACEUTICALS INC.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.